MedPath

A randomized trial of electrical stimulation of the brain for management of psychogenic seizures

Not Applicable
Conditions
Health Condition 1: F445- Conversion disorder with seizuresor convulsions
Registration Number
CTRI/2024/01/061260
Lead Sponsor
ONE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects with psychogenic non-epileptic seizures

1. Aged >18 years

2. Diagnosis of PNES by short term VEEG recording

3. =2 events/month.

Exclusion Criteria

1)Subjects with known epilepsy

2)Subjects with PNES who have significant intellectual disability

3)Severe psychiatric comorbidity and suicidal ideations

4)Pregnant women

5)Those with dementia, psychosis, delirium, scalp infections or lesions

6)Subjects with history of brain surgery or aneurysm clipping or electrical device implantation like pacemaker

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
defined as success if = 50% reduction in event frequency at end of one month compared to baseline. <br/ ><br>Timepoint: defined as success if = 50% reduction in event frequency at end of one month compared to baseline. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Absolute number of events/months at the end of 1,2 & 3 months expressed as median with IQR or mean with SD. Application of 1st sessions of tDCS is considered as day 1. After 30 days from the onset of tDCS patient first time followed and subsequently at 2nd and 3rd month; Safety parameters from the ADR and self-report questionnaire as proportions; Scores on HAM-A, HAM-D, BREF-QOL, QOLIE at the end of 1, 2 and 3 months as median with IQR. <br/ ><br>Timepoint: at end of 2nd & 3rd month
© Copyright 2025. All Rights Reserved by MedPath